Tongling Jieya Biologic Technology Co., Ltd. Stock

Equities

301108

CNE1000054S9

Personal Products

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-24 pm EDT 5-day change 1st Jan Change
26.92 CNY +2.32% Intraday chart for Tongling Jieya Biologic Technology Co., Ltd. +5.12% -22.06%
Sales 2024 * 720M 99.37M Sales 2025 * 825M 114M Capitalization 2.18B 301M
Net income 2024 * 134M 18.49M Net income 2025 * 157M 21.67M EV / Sales 2024 * 3.03 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 2.65 x
P/E ratio 2024 *
16.2 x
P/E ratio 2025 *
-
Employees 620
Yield 2024 *
1.56%
Yield 2025 *
1.82%
Free-Float 28.37%
More Fundamentals * Assessed data
Dynamic Chart
Tongling Jieya Biologic Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Tongling Jieya Biologic Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Tongling Jieya Biologic Technology Co., Ltd. commences an Equity Buyback Plan for CNY 40 million worth of its shares, under the authorization approved on March 13, 2024. CI
Certain A Shares of Tongling Jieya Biologic Technology Co., Ltd. are subject to a Lock-Up Agreement Ending on 4-DEC-2023. CI
Tongling Jieya Biologic Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Tongling Jieya Biologic Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Tongling Jieya Biologic Technology Co., Ltd. agreed to acquire 20% stake in Sateri Nonwoven Materials Co., Ltd. from Sateri Fiber Co., Ltd. for CNY 16.5 million. CI
Tongling Jieya Biologic Technology Co., Ltd. Approves Cash Dividend on A shares for 2022, Payable on 26 May 2023 CI
Tongling Jieya Biologic Technology Co., Ltd. Proposes Final Cash Dividend for 2022 CI
Tongling Jieya Biologic Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Certain A Shares of Tongling Jieya Biologic Technology Co., Ltd. are subject to a Lock-Up Agreement Ending on 4-DEC-2022. CI
Tongling Jieya Biologic Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Tongling Jieya Biologic Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Tongling Jieya Biologic to Free Up More than 1 Milion Shares For Trading MT
Tongling Jieya Biologic Technology Co., Ltd. Approves Final Cash Dividend for the Year 2021 CI
More news
1 day+2.32%
1 week+5.12%
Current month-4.47%
1 month-4.34%
3 months-11.59%
6 months-19.30%
Current year-22.06%
More quotes
1 week
25.52
Extreme 25.52
27.04
1 month
24.45
Extreme 24.45
29.20
Current year
23.14
Extreme 23.14
35.58
1 year
23.14
Extreme 23.14
39.30
3 years
23.14
Extreme 23.14
97.58
5 years
23.14
Extreme 23.14
97.58
10 years
23.14
Extreme 23.14
97.58
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 99-08-30
Chairman 41 18-07-31
Chief Administrative Officer 54 04-03-31
Members of the board TitleAgeSince
Chairman 41 18-07-31
Chief Executive Officer 54 99-08-30
Director/Board Member 50 99-07-31
More insiders
Date Price Change Volume
24-04-25 26.92 +2.32% 407,500
24-04-24 26.31 +0.04% 265,100
24-04-23 26.3 +0.38% 277,400
24-04-22 26.2 +2.26% 383,068
24-04-19 25.62 +0.04% 311,100

End-of-day quote Shenzhen S.E., April 24, 2024

More quotes
Tongling Jieya Biologic Technology Co Ltd is a China-based company mainly engaged in the production of wipes. The Company's main businesses are the research and development, production and sales of sanitary products. The Company's wet wipes products include baby series, adult functional series, antibacterial disinfection series, household cleaning series, medical care series and pet cleaning series. The Company is also engaged in the production of facial masks.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
26.92 CNY
Average target price
35 CNY
Spread / Average Target
+30.01%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 301108 Stock